4-Fluoro-7-(Methylsulfonyl)-2,3-Dihydro-1H-Inden-1-One

4-Fluoro-7-(Methylsulfonyl)-2,3-Dihydro-1H-Inden-1-One
Product Description

Intermediates of belzutifan

Suraj Laboratories

  • IN
  • 2024
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Generics/Biosimilars Manufacturer
Primary activities
API Producer
Specifications
  • CAS Registry Number
    1672665-29-0
  • Details
    Belzutifan
  • Model
    1672665-29-0
  • Measured In
    gram

Suraj Laboratories

  • IN
  • 2024
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Generics/Biosimilars Manufacturer
Primary activities
API Producer

More Products from Suraj Laboratories (53)

Suraj Laboratories resources (2)

Frequently Viewed Together

  • Product REISHI FORTE

    The REISHI Forte food supplement is a 100% natural product which contains the whole dried reishi mushroom coming from a certified reishi farm in the EU. It is processed using a gentle drying process (lyophilisation), thanks to which the mushroom retains all biologically active substances acting in synergy....
  • Product EVER Pharma Product List

    Our products include: Atosiban Cabazitaxel Cebrium(R) Cerebrolysin(R) Dacepton(R) Dexmedetomidine Docetaxel Fulvestrant MemoProve(R) Oxytocin Paclitaxel Pemetrexed Tachyben(R) Terlipressin
  • Product PROBIOSPRAY

    Sprayable Lactobacillus rhamnosus GG in oil. Double care: immunity and oral health for children. Efficacy clinically proven.
  • Product Peg-asparaginase & other oncology products

    • Vandetanib tablets • L - Asparaginase injection • Peg - Asparaginase injection • Thiotepa injection • Melphalan injection • Paclitaxel Albumin bound nanoparticle injection • Plerixafor injection and more...
  • Product . Gobi Gold Daily Balancer®

    •one powerful capsule contains 20 essenial ingredients • Scientifically advanced to balance nutrition.
    • Tackles the lack of balance in most people’s diets
    • For the first time combined, incorporating innovativetechnologies to achieve maximum effectiveness.
    • High quality nu...
  • Product Gobi Gold® Gen!us

    -GG kids contains X 3 more Omega 3s EPA & DHA, compared to common gummy vitaminsGGKids due to the use of an innovative technology, managed to incorporate more than 250 mg of DHA, a quantity proven to contribute to brain development in children, an amount of omega 3s, approved to contribute to normal br...
  • Product Nasafytol® - NutraIngredients Awards WINNER -

    Discover the double award-winner Nasafytol® and its unique formula born from extensive research at the Tilman® laboratory. Nasafytol®contains highly concentrated plant active ingredients chosen for their unique qualities and controlled origins.
    Choose Nasafytol® for a straightforward, top-quality, pla...
  • Product Mitomycin

    Substipharm offers a wide range of products which includes Mitocin 20mg is indicated for intravesical administration for relapse prevention in superficial urinary bladder carcinoma after transurethral resection 1.

    It can also be used Intravenously as monochemotherapy or in combined c...
  • Product products

    Tablets 1ZefinibGefitinib250mg1 x 10 2CapetazCapecetabine500mg1 x 10 3AnastrozAnastrozole1mg1 x 10 4ZutamTamoxifen20mg1 x 10 5ZuvitrexMethotrexate 2.5mg1 x 10 6ZuvitrexMethotrexate7.5mg1 x 10 7ErlononErlotinib100mg1 x 10 8ErlononErlotinib150mg1 x 10 9ZuvitrozLetrozole...
  • Product Eliglustat

    Is used to treat Gaucher disease which is a fat storage disorder. Eliglustat is available in 84mg hard capsules. Coripharma`s generic version of Eliglustat is being developed in our R&D facility located in Iceland, which is run solely on sustainable energy. We plan to have the dossier available in Q1 2...
  • Product Ruxolitinib

    Ruxolitinib is used for the treatment of symptoms in adult patients with primary myelofibrosis which is a rare form of blood cancer. Ruxolitinib tablets come in four strengths, 5 mg, 10 mg, 15 mg and 20 mg. Pivotal BE study is completed and passing. Dossier is available and DCP slot confirmed in January 20...